This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 sales and PAT rise, but exceptional gains mask weaker standalone profit
BLUESTARCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts less than Nifty Midcap 150 and 0.1 pts less than its Household Appliances peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Blue Star approved unaudited Q2 and H1 FY2027 results. Consolidated Q2 revenue rose 21.0% year on year to 2,930.95 crore and PAT rose 25.4% to 123.91 crore; EPS was 6.03. H1 revenue rose 16.7% to 6,308.87 crore, but PAT rose only 3.1% to 226.42 crore. The Q2 operating EBITDA margin fell to 6.91% from 7.57%. H1 included 32.19 crore of exceptional gains from Medtech and property sales. Standalone H1 PAT fell about 42% to 107.60 crore.
Higher sales and headline profit support sentiment, but margin compression and exceptional gains make the improvement less sustainable.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹2,931 Cr | ₹2,422 Cr | +21.0% |
| Operating profit | ₹117.8 Cr | ₹123.1 Cr | −4.3% |
| Profit after tax | ₹123.9 Cr | ₹98.78 Cr | +25.4% |
| EBITDA margin | 7.7% | 7.6% | +0.1 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.